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Abstract 
We report a case of an 8-year-old male
patient with Evans syndrome and severe
hypogammaglobulinemia, subsequently in
whom the 22q11.2 deletion syndrome (22q11.2
DS) was diagnosed. No other clinical sign of
22q11.2 DS was present with the exception of
slight facial dysmorphism. The case is of par-
ticular interest because it suggests the need to
research chromosome 22q11.2 deletion in
patients who present with autoimmune
cytopenia and peculiar facial abnormalities,
which could be an atypical presentation of an
incomplete form of 22q11.2 DS.
Introduction
Chromosome 22q11.2 deletion syndrome
(22q11.2 DS) is considered the most common
human deletion syndrome with an estimated
incidence of 1:4000 live births.1 More than 90%
of the patients are hemizygous for a 1.5-3 Mb
deletion within the 22q11.2 region.2 The clin -
ical expressivity of the syndrome is highly vari-
able comprising more than 100 phenotypes,
the DiGeorge syndrome, velocardiofacial syn-
drome, and conotruncal anomaly face syn-
drome being the most frequent. It is character-
ized mainly by facial anomalies, congenital
cardiac defects, thymic and parathyroid
hypoplasia or aplasia, resulting in T-cell
immunodeficiency and hypocalcemia. Other
common findings are velopharyngeal insuffi-
ciency, genito-urinary anomalies, learning dif-
ficulties, and psychiatric disorders. An early
diagnosis of the syndrome is extremely import -
ant to assure all the necessary interventions
for the different clinical aspects.
Case Report
A 12-month-old boy presented at our hos -
pital with mucosal bleeding and diffuse skin
petechiae. His previous clinical history
revealed that he is the second child of healthy
nonconsanguineous parents. Intrauterine
growth retardation was noted during the sec-
ond trimester of gestation. Neonatal seizures
associated with an abnormal EEG occurred at
day 2 of life. At the age of seven months, a V-
grade vesicoureteral reflux was diagnosed and
surgical correction was performed. The baby
was examined by the geneticist who asked for
conventional cytogenetic analysis: the karyo -
type result was normal (46, XY). At four years
of age he had three episodes of afebrile
seizures. Magnetic resonance imaging showed
a slight alteration of the focal frontal subcor -
tical signal, interpreted as a possible outcome
of perinatal hypoxic-ischemic insult.
At the clinical examination the boy was in a
severe general condition, pale with scleral
icterus. His liver was palpable 5 cm below the
costal margin, and the spleen was enlarged, 1
cm below the costal margin. The laboratory
assessment showed leukocyte counts of 14600
cells/μL, neutrophils 3400 cells/μL, lympho-
cytes 11060 cells/μL, hemoglobin 4.8 g/dL,
platelets 10000/μL, bilirubin 4.9 mg/dL, all
unconjugated. The direct Coombs’ test was
positive. Serum immunoglobulin levels were
normal for his age (IgG 518 mg/dL, IgA 87
mg/dL, IgM 116 mg/dL). The child was treated
with prednisone and intravenous immuno -
globulin (IVIg) with complete resolution of
symptoms. In the following years, recurrent
episodes of bleeding associated with thrombo-
cytopenia and other episodes of acute hemoly-
sis occurred, and a chronic treatment with cor-
ticosteroids was employed; on one occasion a
further IVIg treatment was necessary to recov-
er a good platelet level. Because of the combin -
ation of immune thrombocytopenia and
autoimmune hemolytic anemia, Evans syn-
drome was diagnosed. A recent study has
demonstrated that numerous patients with
Evans syndrome may have autoimmune
lympho prolipherative syndrome.3,4 Therefore,
because of cytopenia, persistent hepato -
splenomegaly, and the finding of cervical
lymph adenopathy, FAS-mediated apoptosis
was analyzed in our patient, despite the nor-
mal results. The number of CD3+CD4–CD8–
cells was never tested. Moreover, since the age
of one year he has suffered from recurrent re -
spiratory infections and frequent episodes of
gastroenteritis.
When he was seven years old, he was admit-
ted to our hospital because of one episode of
fever, coughing, vomiting, and abdominal pain.
A chest X-ray showed bronchopneumonia.
Laboratory investigations were carried out and
showed low levels of γ-globulin on serum pro-
tein electrophoresis (0.35 g/dL; 5.4%, normal
range: 7.7-17%) with normal serum albumin
(4.5 g/dL, 65.5%). Immunoglobulin levels were
tested and found to be impaired: IgG 283 mg/dL
(age-related normal range: 625-1165 mg/dL),
IgA undetectable, and IgM 87 mg/dL. The
lympho cyte subsets (Table 1) showed slightly
low CD3+ and CD4+ T cells, when compared to
normal age values. Antibody responses to
tetanus and to hemophilus B antigens were
poor (tetanus IgG 0.2 IU/mL, hemophilus B IgG
2.5 mg/L). Based on the finding of hypogam-
maglobulinemia with normal B cell number,
common variable immunodeficiency was sus-
pected initially and replacement therapy with
intravenous immunoglobulin was started. A
dose of 400 mg/kg was administrated every 28
days. Because of his clinical history, a second
examination by a clinical geneticist was
requested in February 2009: mild but signifi-
cant facial abnormalities were noticed (narrow
palpebral fissures, a slightly bulbous nose with
hypoplastic nares, large and low-set ears), and
a 22q11. DS was clinically suspected and then
confirmed by FISH analysis. Therefore a diag-
nosis of partial DiGeorge syndrome was made.
Consequently, a cardiological evaluation
was performed and no congenital heart defect
was found. The ENT evaluation showed slight
velopharyngeal insufficiency that justified his
nasal speech. Bone mass and metabolism were
normal (ionized and total calcium, phosphate,
parathyroid hormone, 25-hydroxyvitamin D,
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1,25-dihydroxyvitamin D, serum osteocalcin
levels, urinary deoxipyridinoline concentra-
tion, and dual energy X-ray absorptiometry
were evaluated). Neonatal hypocalcemia was
never detected, and titanic seizures or tremori
were never shown. Besides immunological and
hematological follow-up, an educational
assess ment was performed and the child was
introduced to a neuropsychological follow-up.
Discussion
The immunodeficiency arises as a conse-
quence of thymic hypoplasia in patients with
the deletion syndrome. Patients with a com-
plete absence of the thymus (“complete”
DiGeorge syndrome) exhibit severe T-cell
immu nodeficiency with a severe combined
immunodeficiency phenotype requiring
immune reconstitution by bone marrow trans-
plantation or thymic transplantation.5-7
However, “complete” DiGeorge syndrome
accounts for <1% of patients.8,9 The majority of
patients with 22q11.2 DS and immune defects
exhibit mild to moderate deficits in T-cell num-
bers (so-called “partial” DiGeorge syndrome).
Studies of humoral deficiencies in 22q11.2 DS
patients have yielded conflicting results.9-12
Evidence of partial antibody deficiency (IgA
deficiency, IgM deficiency, IgG subclass defi-
ciency, specific antibody deficiency, or specific
antibody responses to pneumococcal polysac-
charide antigen) has been reported rarely,11,13,14
but no mention of a deficiency of almost two
classes of antibodies associated with chromo-
some 22q11.2 DS is found in the literature.
In the 22q11.2 DS, autoimmune disease may
occur in up to 30% of patients and includes
autoimmune cytopenias, autoimmune endo -
crinopathies, and autoimmune arthritis.15-18
Previous studies reported cases of autoim-
mune hemolytic anemia and immune throm-
bocytopenia, but only a few patients with
Evans syndrome have been described.15,16,19-21 To
the best of our knowledge, the association of
Evans syndrome, hypogammaglobulinemia,
and 22q11.2 DS has not been reported before.
Early diagnosis of 22q11.2 DS is extremely
important for early evaluation of all the clinical
and functional aspects of the syndrome
(endocrine, immunological, cardiac, neuropsy-
chiatric, etc.), so as to begin a prompt thera-
peutic program. We concluded that hematolo-
gists should consider the possibility of the
22q11.2 DS in children of all ages who present
with Evans syndrome associated with hypo -
gammaglobulinemia and mild facial anom-
alies.
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Table 1. Lymphocyte subsets – absolute number.
Lymphocytes Patient (cells/µL) Age-related normal value (cells/µL) 
CD19+ 517 300-700
CD3+ 1053 1100-2800
CD3+CD4+ 574 500-1800
CD3+CD8+ 398 400-1200
CD3–CD16+CD56+ 149 100-600
CD4/CD8 1.4 1.4-2.7
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